Pfizer CEO says there will be no generic Paxlovid for China
11 Articles
11 Articles
Pfizer CEO says there will be no generic Paxlovid for China
BEIJING, Jan 10 ― Pfizer Inc is not in talks with Chinese authorities to license a generic version of its Covid-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive Albert Bourla said yesterday. Reuters reported on Friday that China was in talks with Pfizer to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's Covid-19 …
Pfizer CEO rules out generic COVID drug Paxlovid for China
Pfizer Inc is not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive Albert Bourla said on Monday.
Coverage Details
Bias Distribution
- 44% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage